Sector revisions Eisai Co., Ltd.

Stocks

Market Closed - Japan Exchange Other stock markets 12:00:00 17/07/2026 pm IST			5-day change	1st Jan Change
4,450.00 ^JPY	+2.58%		+3.58%	-4.51%

15/07	Bioarctic AB Partner Eisai Presents Real-World Leader Study Results for Leqembi in Early Alzheimer?S Disease	CI
14/07	Eisai Co., Ltd. and Biogen Inc. Present Real-World LEADER Study Results For LEQEMBI At AAIC 2026	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	EISAI CO., LTD.							14
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	VERTEX PHARMACEUTICALS INCORPORATED							23
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	BAYER AG							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	HALEON PLC							17
	Average							21
	Weighted average by Cap.							24